(Q53636330)

16 May 2018

title

Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer. (English)

1 reference

16 May 2018

author name string

J Wang

1

1 reference

16 May 2018

T R McGuire

2

1 reference

16 May 2018

H C Britton

3

1 reference

16 May 2018

J K Schwarz

4

1 reference

16 May 2018

F R Loberiza

5

1 reference

16 May 2018

J L Meza

6

1 reference

16 May 2018

J E Talmadge

7

1 reference

16 May 2018

publication date

25 January 2015

1 reference

16 May 2018

Clinical & Experimental Metastasis

published in

1 reference

16 May 2018

volume

32

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

111-124

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s10585-015-9696-3

exact match

0 references

cites work

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

History of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Lenalidomide monotherapy in chemotherapy-naive, castration-resistant prostate cancer patients: final results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Phase I study of oral lenalidomide in patients with refractory metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): results from a phase I-II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Regulatory T cells: recommendations to simplify the nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Fate decisions regulating bone marrow and peripheral B lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Effects of ozone exposure on inactivation of intra- and extracellular enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

The ageing B cell population: composition and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9696-3

21 January 2018

1 reference

12 December 2020

Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma

1 reference

12 December 2020

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases

1 reference

12 December 2020

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells

1 reference

12 December 2020

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide

1 reference

12 December 2020

Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation

1 reference

12 December 2020

Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients.

1 reference

12 December 2020

DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment

1 reference

12 December 2020

Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products

1 reference

12 December 2020

Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood

1 reference

12 December 2020

Effects of anticancer drugs on the immune system in humans

1 reference

12 December 2020

Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation

1 reference

12 December 2020

Expression of interleukin-10 in isolated CD8+ T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction

1 reference

12 December 2020

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

1 reference

12 December 2020

Inflammation and prostate cancer: the role of interleukin 6 (IL-6).

1 reference

12 December 2020

Monocytes from mobilized stem cells inhibit T cell function

1 reference

12 December 2020

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

1 reference

12 December 2020

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

1 reference

12 December 2020

Nutritional indicators, peripheral blood lymphocyte subsets and survival in an institutionalised elderly population.

1 reference

12 December 2020

10.1007/S10585-015-9696-3

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018